Drug
Triiodothyronine clinical trials
Also written Liothyronine, Cytomel and Triostat.
- studies test it
- 42
- open now
- 3
- in phase 3
- 7
- first study started
- 1996
Keep track of what changes. Save the Triiodothyronine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Other names
- T3
- 3
Studies by the year they started
42 studies that test it; most in 2015 (4)
| Year | Studies |
|---|---|
| 1996 | 1 |
| 2001 | 3 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 3 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 8
- Phase 2
- 13
- Phase 3
- 7
- Phase 4
- 5
- No phase
- 12
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 39
University of Pennsylvania (4) · Emory University (3) · Virginia Commonwealth University (2) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2) · Stanford University (2) · Ipe, LLC (2) · Hadassah Medical Organization (2) · Seattle Children's Hospital (1)
Often tested with
Tested in the same studies.
Thyroxine (8) · Sertraline (1) · Reboxetine (1) · Testosterone enanthate (1) · Testosterone (1) · Testosterone 17 beta-cypionate (1) · Testosterone Propionate (1) · Methenolone enanthate (1)
Studies
Open first, then newest update. How each study uses Triiodothyronine is read from its arms, and is right about nine times in ten.
Testing it · 42
- T4/T3 Therapy in HypothyroidismNot yet recruitingPhase 2University of PennsylvaniaNCT07424183Written as Liothyronine (L-T3)
- Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite AthletesEnrolling by invitationNot applicableEnhanced Emirates LimitedNCT07568574Written as Liothyronine
- LT4/LT3 Combination Therapy Versus LT4 Monotherapy in Patients with Autoimmune Hypothyroidism.RecruitingPhase 3M. MediciNCT05682482Written as LT3 (liothyronine)
- Effects of Triiodothyronine (T3) in Ischemic Heart FailureCompletedPhase 1Emory UniversityNCT05384847Written as Thyroid hormone T3
- Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to Radiation TherapyTerminatedPhase 1Mayo ClinicNCT00788307Written as Liothyronine Sodium
- Developing Oral LT3 Therapy for Heart Failure - HFpEFCompletedPhase 1/2University of PennsylvaniaNCT04111536Written as liothyronine
- Developing Oral LT3 Therapy for Heart Failure - HFrEFCompletedPhase 1/2University of PennsylvaniaNCT04112316Written as Liothyronine
- Energy Metabolism in Thyroidectomized PatientsCompletedPhase 2Virginia Commonwealth UniversityNCT04782856Written as Liothyronine
- Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary BypassCompletedPhase 3Seattle Children's HospitalNCT02320669Written as Triostat
- Thyroid Hormone Supplementation in Patients With Septic ShockCompletedPhase 2Cantonal Hospital ZenicaNCT05270798Written as triiodothyronine
- Combined Replacement Therapy With Levothyroxine and Liothyronine in Thyroidectomized PatientsCompletedPhase 2/3Azienda USL ModenaNCT03053115Written as Liothyronine
- Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or GliosarcomaWithdrawnEarly Phase 1Emory UniversityNCT05017610Written as Liothyronine
- Study of Euthyroid Hypothyroxinemia in Metastatic Breast CarcinomaTerminatedPhase 2Aultman Health FoundationNCT03787303Written as Triiodothyronine (T3)
- Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.Status unknownPhase 4Zhongshan Hospital Xiamen UniversityNCT05247476Written as L-T4+T3 (thyroid tablet)
- Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 InfectionTerminatedPhase 2Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.NCT04348513Written as T3 solution for injection
- Effects of Liothyronine on Energy Expenditure and Cardiovascular FunctionCompletedPhase 1/2Virginia Commonwealth UniversityNCT03098433Written as Liothyronine
- Identification of Non-responders to Levothyroxine TherapyCompletedPhase 2Oslo University HospitalNCT03627611Written as Liothyronine
- Mechanistic Study of Subclinical Hypothyroidism In the ElderlyCompletedNot applicableUniversity of PennsylvaniaNCT02399475Written as Liothyronine
- Thyroid Hormone to Induce Non-Insulin Mediated Glucose Disposal in People With Insulin Receptor MutationsCompletedPhase 2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT02457897Written as Liothyronine
- Liothyronine and Heart Failure. The Long Term Effect of Liothyronine on Left Ventricular Ejection Fraction (LVEF)CompletedNot applicableJens FaberNCT01481402Written as Liothyronine
See all 42 studies that test Triiodothyronine →
Given in every arm · 2 — Triiodothyronine is usual care beside what is tested
- Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual DiseaseRecruitingPhase 1/2Sabine Mueller, MD, PhDNCT07346157Written as Liothyronine (L-T3)
- 131I-Omburtamab, in Recurrent Medulloblastoma and EpendymomaActive, not recruitingPhase 2Pediatric Brain Tumor ConsortiumNCT04743661Written as Liothyronine
As the comparator · 1 — what is tested is compared with Triiodothyronine
Codes
What other systems call Triiodothyronine · ClinicalTrials.gg INT008359
- MeSH (NLM) D014284TriiodothyronineConfirmed NLM, Wikidata
- UNII (FDA) 06LU7C9H1VLIOTHYRONINEConfirmed FDA, NLM, Wikidata
- RxNorm 10814Confirmed FDA, Wikidata
- Wikidata Q327362triiodothyronineConfirmed FDA, NLM, Wikidata
- DrugBank DB00279One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D014284 | Triiodothyronine | Confirmed NLM, Wikidata |
| UNII (FDA) | 06LU7C9H1V | LIOTHYRONINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 10814 | — | Confirmed FDA, Wikidata |
| Wikidata | Q327362 | triiodothyronine | Confirmed FDA, NLM, Wikidata |
| DrugBank | DB00279 | — | One source Wikidata |
Also registered as liothyronine sodium (UNII GCA9VV7D2N · RxNorm 142448).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.